Johnson & Johnson (NYSE: JNJ), fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular (NASDAQ: ITCI), reported fourth-quarter […]
Johnson & Johnson Beats Q4 Sales and Profit Estimates on Cancer Drug Sales Read More »
On Monday, Johnson & Johnson (NYSE: JNJ) said it would buy neurological drug maker Intra-Cellular Therapies (NASDAQ: ITCI) for $14.6
Johnson & Johnson to Buy Neurological Drug Maker Intra-Cellular for $14.6 Billion Read More »
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to
US FDA Proposes Standardized Testing to Detect Asbestos in Talc Products Read More »
Johnson & Johnson (NYSE: JNJ) must pay $15 million to a Connecticut man who alleges that he developed mesothelioma, a
Johnson & Johnson Ordered to Pay $15 Million in Talc Powder Cancer Case Read More »
Johnson & Johnson (NYSE: JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology
Johnson & Johnson (NYSE: JNJ) Posts Better-than-Expected Q3 Results, Raises 2024 Outlook Read More »
NEW YORK – A Johnson & Johnson (NYSE: JNJ) subsidiary can pursue its third attempt to resolve tens of thousands
J&J Talc Bankruptcy Stays in Texas Despite ‘Forum-Shopping’ Opposition Read More »
On Tuesday, Johnson & Johnson (NYSE: JNJ) said it will invest more than $2 billion to build a new manufacturing
A Johnson & Johnson (NYSE: JNJ) subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant
A state judge in Oregon has overturned a jury’s $260 million verdict against Johnson & Johnson (NYSE: JNJ) in a
Copyright © 2025 abbonews.com
